Dose-response Met-Rantes treatment of experimental periodontitis: A narrow edge between the disease severity attenuation and infection control

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Repeke, Carlos Eduardo ^a   Ferreira, Samuel Barros ^a   Vieira, Andreia Espindola ^a   Silveira, Elcia Maria ^a   Avila Campos, Mario Julio ^a   da Silva, João Santana ^a   Santos, Carlos Ferreira ^a   Campanelli, Ana Paula ^a   Trombone, Ana Paula Favaro ^b   Garlet, Gustavo Pompermaier ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO LAURO DE SOUZA LIMA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD19 ANTIGEN; CHEMOKINE RECEPTOR CCR5 ANTAGONIST; IMMUNOGLOBULIN G; INDUCIBLE NITRIC OXIDE SYNTHASE; MET RANTES; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BIOLOGICAL MARKER; CYTOKINE; RANTES; RANTES, MET; RANTES, MET-;

ALVEOLAR BONE LOSS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; CELL MIGRATION; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MECHANISM; IMMUNOREGULATION; INFECTION CONTROL; INFLAMMATORY CELL; MALE; MOUSE; NONHUMAN; PERIODONTITIS; ANIMAL; C57BL MOUSE; DISEASE MODEL; DRUG EFFECT; METABOLISM; MICROBIOLOGY; NEUTROPHIL CHEMOTAXIS; PASTEURELLACEAE; PASTEURELLACEAE INFECTION; PATHOGENICITY; PATHOLOGY; TREATMENT OUTCOME;

BACTERIA (MICROORGANISMS); MUS;

ANIMALS; ANTI-INFECTIVE AGENTS; BIOLOGICAL MARKERS; CHEMOKINE CCL5; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MICE, INBRED C57BL; PASTEURELLACEAE; PASTEURELLACEAE INFECTIONS; PERIODONTITIS; TREATMENT OUTCOME;

EID: 79960571145     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022526     Document Type: Article

References (45)

1. Cochran DL, (2008) Inflammation and bone loss in periodontal disease. J Periodontol 79: 1569-1576.
2. Garlet GP, (2010) Destructive and protective roles of cytokines in periodontitis: a re-appraisal from host defense and tissue destruction viewpoints. J Dent Res 89: 1349-1363.
3. Garlet GP, Avila-Campos MJ, Milanezi CM, Ferreira BR, Silva JS, (2005) Actinobacillus actinomycetemcomitans-induced periodontal disease in mice: patterns of cytokine, chemokine, and chemokine receptor expression and leukocyte migration. Microbes Infect 7: 738-747.
4. Silva TA, Garlet GP, Fukada SY, Silva JS, Cunha FQ, (2007) Chemokines in oral inflammatory diseases: apical periodontitis and periodontal disease. J Dent Res 86: 306-319.
5. Bachmann MF, Kopf M, Marsland BJ, (2006) Chemokines: more than just road signs. Nat Rev Immunol 6: 159-164.
6. Baggiolini M, (1998) Chemokines and leukocyte traffic. Nature 392: 565-568.
7. Garlet GP, Martins W Jr, Ferreira BR, Milanezi CM, Silva JS, (2003) Patterns of chemokines and chemokine receptors expression in different forms of human periodontal disease. J Periodontal Res 38: 210-217.
8. Gamonal J, Acevedo A, Bascones A, Jorge O, Silva A, (2001) Characterization of cellular infiltrate, detection of chemokine receptor CCR5 and interleukin-8 and RANTES chemokines in adult periodontitis. J Periodontal Res 36: 194-203.
9. Gamonal J, Bascones A, Jorge O, Silva A, (2000) Chemokine RANTES in gingival crevicular fluid of adult patients with periodontitis. J Clin Periodontol 27: 675-681.
10. Repeke CE, Ferreira SB Jr, Claudino M, Silveira EM, de Assis GF, et al. Evidences of the cooperative role of the chemokines CCL3, CCL4 and CCL5 and its receptors CCR1+ and CCR5+ in RANKL+ cell migration throughout experimental periodontitis in mice. Bone 46: 1122-1130.
11. Proudfoot AE, (2002) Chemokine receptors: multifaceted therapeutic targets. Nat Rev Immunol 2: 106-115.
12. Ferreira SB Jr, Repeke CE, Raimundo FM, Nunes IS, Avila-Campos MJ, et al. J Dent Res CCR5 Mediates Pro-osteoclastic and Osteoclastogenic Leukocyte Chemoattraction.
13. Yu X, Huang Y, Collin-Osdoby P, Osdoby P, (2004) CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts. J Bone Miner Res 19: 2065-2077.
14. Garred P, Madsen HO, Petersen J, Marquart H, Hansen TM, et al. (1998) CC chemokine receptor 5 polymorphism in rheumatoid arthritis. J Rheumatol 25: 1462-1465.
15. Oba Y, Lee JW, Ehrlich LA, Chung HY, Jelinek DF, et al. (2005) MIP-1alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells. Exp Hematol 33: 272-278.
16. Szekanecz Z, Kim J, Koch AE, (2003) Chemokines and chemokine receptors in rheumatoid arthritis. Semin Immunol 15: 15-21.
17. Bertolini A, Ottani A, Sandrini M, (2001) Dual acting anti-inflammatory drugs: a reappraisal. Pharmacol Res 44: 437-450.
18. Eming SA, Hammerschmidt M, Krieg T, Roers A, (2009) Interrelation of immunity and tissue repair or regeneration. Semin Cell Dev Biol 20: 517-527.
19. Ferreira SB Jr, Repeke CE, Raimundo FM, Nunes IS, Avila-Campos MJ, et al. (2011) CCR5 Mediates Pro-osteoclastic and Osteoclastogenic Leukocyte Chemoattraction. J Dent Res in press.
20. Proudfoot AE, Power CA, Hoogewerf AJ, Montjovent MO, Borlat F, et al. (1996) Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist. J Biol Chem 271: 2599-2603.
21. Doodes PD, Cao Y, Hamel KM, Wang Y, Rodeghero RL, et al. (2009) CCR5 is involved in resolution of inflammation in proteoglycan-induced arthritis. Arthritis Rheum 60: 2945-2953.
22. Kucuk C, Sozuer E, Gursoy S, Canoz O, Artis T, et al. (2006) Treatment with Met-RANTES decreases bacterial translocation in experimental colitis. Am J Surg 191: 77-83.
23. Trombone AP, Ferreira SB Jr, Raimundo FM, de Moura KC, Avila-Campos MJ, et al. (2009) Experimental periodontitis in mice selected for maximal or minimal inflammatory reactions: increased inflammatory immune responsiveness drives increased alveolar bone loss without enhancing the control of periodontal infection. J Periodontal Res 44: 443-451.
24. Trombone AP, Claudino M, Colavite P, de Assis GF, Avila-Campos MJ,et al. Periodontitis and arthritis interaction in mice involves a shared hyper-inflammatory genotype and functional immunological interferences. Genes Immun 11: 479-489.
25. Bartold PM, Marshall RI, Haynes DR, (2005) Periodontitis and rheumatoid arthritis: a review. J Periodontol 76: 2066-2074.
26. Garlet GP, Cardoso CR, Campanelli AP, Ferreira BR, Avila-Campos MJ, et al. (2007) The dual role of p55 tumour necrosis factor-alpha receptor in Actinobacillus actinomycetemcomitans-induced experimental periodontitis: host protection and tissue destruction. Clin Exp Immunol 147: 128-138.
27. Proudfoot AE, Power CA, Rommel C, Wells TN, (2003) Strategies for chemokine antagonists as therapeutics. Semin Immunol 15: 57-65.
28. Barcelos LS, Coelho AM, Russo RC, Guabiraba R, Souza AL, et al. (2009) Role of the chemokines CCL3/MIP-1 alpha and CCL5/RANTES in sponge-induced inflammatory angiogenesis in mice. Microvasc Res 78: 148-154.
29. Garlet GP, Cardoso CR, Campanelli AP, Garlet TP, Avila-Campos MJ, et al. (2008) The essential role of IFN-gamma in the control of lethal Aggregatibacter actinomycetemcomitans infection in mice. Microbes Infect 10: 489-496.
30. Kabashima H, Yoneda M, Nagata K, Hirofuji T, Maeda K, (2002) The presence of chemokine (MCP-1, MIP-1alpha, MIP-1beta, IP-10, RANTES)-positive cells and chemokine receptor (CCR5, CXCR3)-positive cells in inflamed human gingival tissues. Cytokine 20: 70-77.
31. Song E, Zou H, Yao Y, Proudfoot A, Antus B, et al. (2002) Early application of Met-RANTES ameliorates chronic allograft nephropathy. Kidney Int 61: 676-685.
32. Ajuebor MN, Hogaboam CM, Kunkel SL, Proudfoot AE, Wallace JL, (2001) The chemokine RANTES is a crucial mediator of the progression from acute to chronic colitis in the rat. J Immunol 166: 552-558.
33. Shahrara S, Proudfoot AE, Woods JM, Ruth JH, Amin MA, et al. (2005) Amelioration of rat adjuvant-induced arthritis by Met-RANTES. Arthritis Rheum 52: 1907-1919.
34. Graves D, (2008) Cytokines that promote periodontal tissue destruction. J Periodontol 79: 1585-1591.
35. Takayanagi H, (2005) Inflammatory bone destruction and osteoimmunology. J Periodontal Res 40: 287-293.
36. Garlet GP, Cardoso CR, Silva TA, Ferreira BR, Avila-Campos MJ, et al. (2006) Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors. Oral Microbiol Immunol 21: 12-20.
37. Ernst CW, Lee JE, Nakanishi T, Karimbux NY, Rezende TM, et al. (2007) Diminished forkhead box P3/CD25 double-positive T regulatory cells are associated with the increased nuclear factor-kappaB ligand (RANKL+) T cells in bone resorption lesion of periodontal disease. Clin Exp Immunol 148: 271-280.
38. Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, et al. (2004) Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 22: 929-979.
39. Alvarez D, Vollmann EH, von Andrian UH, (2008) Mechanisms and consequences of dendritic cell migration. Immunity 29: 325-342.
40. Satoh J, Nanri Y, Tabunoki H, Yamamura T, (2006) Microarray analysis identifies a set of CXCR3 and CCR2 ligand chemokines as early IFNbeta-responsive genes in peripheral blood lymphocytes in vitro: an implication for IFNbeta-related adverse effects in multiple sclerosis. BMC Neurol 6: 18.
41. Kim CH, (2009) Migration and function of Th17 cells. Inflamm Allergy Drug Targets 8: 221-228.
42. Stojanovic T, Bedke J, Grone HJ, Proudfoot AE, Becker H, et al. (2002) Met-RANTES inhibition of mucosal perfusion failure in acute intestinal transplant rejection- role of endothelial cell-leukocyte interaction. J Vasc Res 39: 51-58.
43. Brandner B, Rek A, Diedrichs-Mohring M, Wildner G, Kungl AJ, (2009) Engineering the glycosaminoglycan-binding affinity, kinetics and oligomerization behavior of RANTES: a tool for generating chemokine-based glycosaminoglycan antagonists. Protein Eng Des Sel 22: 367-373.
44. Alayan J, Ivanovski S, Gemmell E, Ford P, Hamlet S, et al. (2006) Deficiency of iNOS contributes to Porphyromonas gingivalis-induced tissue damage. Oral Microbiol Immunol 21: 360-365.
45. D'Aiuto F, Parkar M, Andreou G, Suvan J, Brett PM, et al. (2004) Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res 83: 156-160.